Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations.

MLA

Rothenberg-Lausell, Camille, et al. “Biologic and Small-Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations.” Journal of Allergy & Clinical Immunology, vol. 154, no. 1, July 2024, pp. 20–30. EBSCOhost, https://doi.org/10.1016/j.jaci.2024.04.009.

APA

Rothenberg-Lausell, C., Bar, J., Dahabreh, D., Renert-Yuval, Y., Del Duca, E., & Guttman-Yassky, E. (2024). Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations. Journal of Allergy & Clinical Immunology, 154(1), 20–30. https://doi.org/10.1016/j.jaci.2024.04.009

Chicago

Rothenberg-Lausell, Camille, Jonathan Bar, Dante Dahabreh, Yael Renert-Yuval, Ester Del Duca, and Emma Guttman-Yassky. 2024. “Biologic and Small-Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations.” Journal of Allergy & Clinical Immunology 154 (1): 20–30. doi:10.1016/j.jaci.2024.04.009.